Journal of the Chinese Medical Association
Volume 69, Issue 5 , Pages 193-198, May 2006

Model for End-stage Liver Disease and Organ Allocation in Liver Transplantation: Where Are We and Where Should We Go?

  • Teh-Ia Huo

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr. Teh-Ia Huo, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, R.O.C.
    • ,
  • Han-Chieh Lin
    • ,
  • Shou-Dong Lee

Department of Medicine, Taipei Veterans General Hospital, and National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.

Received 13 October 2005; accepted 28 March 2006.

Article Outline

The Child-Turcotte-Pugh (CTP) score has been used for decades to measure the severity of chronic liver disease. Recent studies have shown that the model for end-stage liver disease (MELD) more accurately predicts the short-and mid-term survival for patients with cirrhosis compared to the CTP system. MELD, which has 3 parameters (serum bilirubin, creatinine, and prothrombin time) that need logarithmic transformation, has the advantage of a wide-range continuous scale and is more objective and less variable. The liver allocation system has changed from a status-based algorithm using the CTP score, to one using a continuous MELD severity score as a reference system to prioritize adult patients on the waiting list since 2002 in the USA. However, there are potential limitations of MELD. An intrinsic defect is that some important parameters, such as hepatic encephalopathy and ascites, which are common adverse complications in cirrhosis, are not included in MELD. It has been suggested to incorporate a low serum sodium level into the prognostic model to enhance the predictive ability. Moreover, the change of MELD over time may provide updated information for patients on the transplant waiting list. In summary, although there was encouraging evidence supporting the prognostic advantage of MELD, the optimal role of MELD in the setting of outcome assessment for cirrhotic patients needs more study. Appropriate modifications and fine tuning of MELD are necessary for determining the ranking status of patients on the waiting list, to avoid a futile transplantation and improve overall patient survival.

Key Words:  liver cirrhosis , liver transplantation , MELD

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, et al  A prognostic model for predicting survival in cirrhosis with ascites . J Hepatol . 2001;34:46–52
  2. Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis . Hepatology . 2000;32:930–934
  3. Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, et al. The prognostic significance of subclinical hepatic encephalopathy . Am J Gastroenterol . 2000;95:2029–2034
  4. Gluud C , Henriksen JH , Nielsen G . Prognostic indicators in alcoholic cirrhotic men . Hepatology . 1988;8:222–227
  5. Planas R, Balleste B, Alvarez MA, Rivera M, Montoliu S, Galeras JA, et al  Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients . J Hepatol . 2004;40:823–830
  6. Shetty K , Rybicki L , Carey WD . The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis . Hepatology . 1997;25:1049–1053
  7. Freeman RB , Edwards EB . Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy . Liver Transpl . 2000;6:543–552
  8. Malinchoc M , Kamath PS , Gordon FD , Peine CJ , Rank J , ter Borg PC . A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts . Hepatology . 2000;31:864–871
  9. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al  A model to predict survival in patients with endstage liver disease . Hepatology . 2001;33:464–470
  10. Freeman RB , Wiesner RH , Roberts JP , McDiarmid S , Dykstra DM , Merion RM . Improving liver allocation: MELD and PELD . Am J Transplant . 2004;4(Suppl):114–131
  11. Olthoff KM, Brown RS, Delmonico FL, Freeman RB, McDiarmid SV, Merion RM, et al  Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era . Liver Transpl . 2004;10(Suppl):6–22
  12. Eckardt KU . Renal failure in liver disease . Intensive Care Med. . 1999;25:5–14
  13. Hampel H , Bynum GD , Zamora E , El-Serag HB . Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis . Am J Gastroenterol . 2001;96:2206–2210
  14. Huo TI, Wu JC, Huang YH, Chiang JH, Lee PC, Chang FY, et al. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome . Aliment Pharmacol Ther . 2004;19:999–1007
  15. Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, et al  Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt . Gut . 2003;52:879–885
  16. Longheval G, Vereerstraeten P, Thiry P, Delhaye M, le Moine O, Deviere J, et al  Predictive models of short-and long-term survival in patients with nonbiliary cirrhosis . Liver Transpl . 2003;9:260–267
  17. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al  Model for end-stage liver disease (MELD) and allocation of donor livers . Gastroenterology . 2003;124:91–96
  18. Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, et al  MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study . Gut . 2003;52:134–139
  19. Salerno F, Merli M, Cazzaniga M, Valeriano V, Rossi P, Lovaria A, et al  MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt . J Hepatol . 2002;36:494–500
  20. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R, et al. Results of the first year of the new liver allocation plan . Liver Transpl . 2004;10:7–15
  21. Freeman RB , Harper A , Edwards EB . Excellent liver transplant survival rates under the MELD/PELD system . Transplant Proc . 2005;37:585–588
  22. Kanwal F , Dulai GS , Spiegel BM , Yee HF , Gralnek IM . A comparison of liver transplantation outcomes in the pre- vs post-MELD eras . Aliment Pharmacol Ther . 2005;21:169–177
  23. Burton JR , Sonnenberg A , Rosen HR . Retransplantation for recurrent hepatitis C in the MELD era: maximizing utility . Liver Transpl . 2004;10(Suppl):59–64
  24. Srikureja W , Kyulo NL , Runyon BA , Hu KQ . MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis . J Hepatol . 2005;42:700–706
  25. Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, et al  MELD accurately predicts mortality in patients with alcoholic hepatitis . Hepatology . 2005;41:353–358
  26. Farnsworth N , Fagan SP , Berger DH , Awad SS . Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients . Am J Surg. . 2004;188:580–583
  27. Testa R, Testa E, Giannini E, Botta F, Malfatti F, Chiarbonello B, et al  Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after treatment . Aliment Pharmacol Ther . 2003;17:1563–1569
  28. Durand F , Valla D . Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD . J Hepatol . 2005;42(Suppl):100–107
  29. Maddrey WC , Boitnott JK , Bedine MS , Weber FL , Mezey E , White RI . Corticosteroid therapy of alcoholic hepatitis . Gastroenterology . 1978;75:193–199
  30. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis . N Engl J Med. . 1996;334:693–699
  31. Freeman RB , Wiesner RH , Roberts JP , McDiarmid S , Dykstra DM , Merion RM . Improving liver allocation: MELD and PELD . Am J Transplant . 2004;4(Suppl):114–131
  32. Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Huang YH, et al  Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy . Liver Transpl . 2004;10:1507–1513
  33. Huo TI , Wu JC , Lee SD . MELD in liver transplantation: the da Vinci code for the Holy Grail? . J Hepatol . 2005;42:477–478
  34. Huo TI, Lin HC, Lee FY, Hou MC, Lee PC, Wu JC, et al  Occurrence of cirrhosis-related complications is a time dependent prognostic predictor independent of baseline model for end-stage liver disease score . Liver Int . 2006;26:55–61
  35. Yoo HY , Edwin D , Thuluvath PJ . Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites . Am J Gastroenterol . 2003;98:1395–1399
  36. Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, et al  Different model for end-stage liver disease score block distributions may have a variable ability for outcome prediction in cirrhotic patients . Transplantation . 2005;80:1414–1418
  37. Biggins SW , Rodriguez HJ , Bacchetti P , Bass NM , Roberts JP , Terrault NA . Serum sodium predicts mortality in patients listed for liver transplantation . Hepatology . 2004;41:32–39
  38. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al  Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death . Hepatology . 2004;40:802–810
  39. Ruf AE , Kremers WK , Chavez LL , Descalzi VI , Podesta LG , Villamil FG . Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone . Liver Transpl . 2005;11:336–343
  40. Merion RM , Wolfe RA , Dykstra DM , Leichtman AB , Gillespie B , Held PJ . Longitudinal assessment of mortality risk among candidates for liver transplantation . Liver Transpl . 2003;9:12–18
  41. Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, et al  Evaluation of the increase in model for end-stage liver disease (?MELD) score over time as a prognostic predictor in patients with advanced liver cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score . J Hepatol . 2005;42:826–832
  42. Bambha K, Kim WR, Kremers WK, Therneau TM, Kamath PS, Wiesner R, et al  Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements . Am J Transplant . 2004;4:1798–1804

PII: S1726-4901(09)70217-5

doi:10.1016/S1726-4901(09)70217-5

Journal of the Chinese Medical Association
Volume 69, Issue 5 , Pages 193-198, May 2006

Article Tools